A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer

Radiation Research

Volumn 178, Issue 4, 2012, Pages 365-376

  Veiga, Lene H S ^a,b   Lubin, Jay H ^a   Anderson, Harald ^c,p   De Vathaire, Florent ^d   Tucker, Margaret ^a   Bhatti, Parveen ^e   Schneider, Arthur ^f   Johansson, Robert ^g   Inskip, Peter ^a   Kleinerman, Ruth ^a   Shore, Roy ^h   Pottern, Linda ⁱ   Holmberg, Erik ^j   Hawkins, Michael M ^k   Adams, M Jacob ^l   Sadetzki, Siegal ^m   Lundell, Marie ⁿ   Sakata, Ritsu ^h   Damber, Lena ^o   Neta, Gila ^a   Ron, Elaine ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b Brazilian Nuclear Energy Commission   (Brazil)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d INSERM   (France)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF ILLINOIS   (United States)

^g UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^h RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

ⁱ U S PUBLIC HEALTH SERVICE   (United States)

^j SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^l UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^m TEL AVIV UNIVERSITY   (Israel)

ⁿ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^o UMEÅ UNIVERSITY   (Sweden)

^p Nordic Countries Childhood Cancer Survival Group   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BLEOMYCIN; EPIPODOPHYLLOTOXIN DERIVATIVE; PLATINUM DERIVATIVE;

AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CHILDHOOD CANCER; DOSE RESPONSE; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION INDUCED NEOPLASM; THYROID CANCER;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; THYROID NEOPLASMS;

EID: 84867080213     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2889.1     Document Type: Article

References (28)

1. Duffy BJ, Fitzgerald PJ. Cancer of the thyroid in children-a report of 28 cases. J Clin Endocrinol 1950; 10:1296-308.
2. Simpson Cl, Hempelmann LH, Fuller LM. Neoplasia in children treated with X-rays in infancy for thymic enlargement. Radiology 1955; 64:840-5.
3. Socolow EL, Niitani R, Hashizume A, Neriishi S. Thyroid carcinoma in man after exposure to ionizing radiation-a summary of findings in Hiroshima and Nagasaki. N Engl J Med 1963; 268:406.
4. Ron E, Schneider AB. Thyroid Cancer. In: Schottenfeld D, Fraumeni Jr., JF. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press, Inc.; 2006.
5. Ron E, Lubin JH, Shore R, Mabuchi K, Modan B, Pottern LM, et al. Thyroid-cancer after exposure to external radiation-a pooled analysis of 7 studies. Radiat Res 1995; 141:259-77.
6. Preston DL, Ron, E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168:1-64.
7. Bhatti P, Veiga LHS, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010; 174:741-52.
8. Poynter JN, Amatruda JF, Ross JA. Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer 2010; 116:4882-91.
9. Baade PD, Youlden DR, Valery PC, Hassall T, Ward L, Green AC, et al. Population-based survival estimates for childhood cancer in Australia during the period 1997-2006. Br J Cancer 2010; 103:1663-70.
10. Bosetti C, Bertuccio P, Chatenoud L, Negri E, Levi F, La Vecchia C. Childhood cancer mortality in Europe, 1970-2007. Eur Cancer 2010; 46:384-94.
11. Desandes E, Berger C, Tron I, Demeocq F, Bellec S, Blouin P, et al. Childhood cancer survival in France, 1990-1999. Eur J Cancer 2008; 44:205-15.
12. Baba S, Ioka A, Tsukuma H, Noda H, Ajiki W, Iso H. Incidence and survival trends for childhood cancer in Osaka, Japan, 1973-2001. Cancer Sci 2010; 101:787-92.
13. Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, Stiller CA, et al. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int J Cancer 2009; 125:2400-5.
14. Mariotto AB, Rowland JH, Yabroff KR, Scoppa S, Hachey M, Ries L, et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomark Prev 2009; 18:1033-40.
15. Veiga LHS, Bhatti P, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Chemotherapy and thyroid cancer risk: A report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomark Prev 2012; 21:92-101.
16. de Vathaire F, Hardiman C, Shamsaldin A, Campbell S, Grimaud E, Hawkins M, et al. Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med 1999; 159:2713-9.
17. Tucker MA, Jones PHM, Boice JD, Robison LL, Stone BJ, Stovall M, et al. Therapeutic radiation at a young age is linked to secondary thyroid-cancer. Cancer Res 1991; 51:2885-8.
18. Svahn-Tapper G, Garwicz S, Anderson H, Shamsaldin A, de Vathaire F, Olsen JH, et al. Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: A population-based casecontrol study in the five Nordic countries. Acta Oncol 2006: 45:438-48.
19. Schisterman EF, Vexler A, Whitcomb BW, Liu AY. The limitations due to exposure detection limits for regression models. Am J Epidemiol 2006; 163:374-83.
20. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ. Health Perspect 2004; 112:1691-6.
21. Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990; 5:46-51.
22. Preston DL, Lubin JH, Pierce DA, McConney ME. Epicure User's Guide. Seattle, WA, USA: HiroSoft International Corporation, Seattle, Washington, 2008.
23. Reulen RC, Winter DL, Frobisher C, Lancashire ER, Stiller CA, Jenney ME, et al. Childhood, Long-term cause-specific mortality among survivors of childhood cancer. J Am Med Assoc 2010; 304:172-9.
24. Landier W, Bhatia S. Cancer survivorship: a pediatric perspective. Oncologist 2008; 13; 1181-92.
25. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci USA 2005; 102:13040-5.
26. Challeton C, Branea F, Schlumberger M, Gaillard N, DeVathaire F, Badie C, et al. Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors. Int J Radiat Oncol Biol Phys 1997; 37: 163-9.
27. Ron E. Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys 2007; 93:502-11.
28. Hall EJ. Is there a place for quantitative risk assessment? J Radiol Prot 2009 29:A171-84.